Issue
Alert me when new journal issues are available via or via
=free full text
Suppl Masthead page IFC Full-Text PDF (33 KB)
Introduction: Proceedings From the 9th Novo Nordisk Symposium on Haemostasis Management E. Carlos Rodriguez-Merchan pages S1-S2 Full Text | Full-Text PDF (61 KB)
Safety
Safety Update on Recombinant Factor VIIa in the Treatment of Congenital and Acquired Hemophilia Thomas Abshire pages S3-S6 Abstract | Full Text | Full-Text PDF (114 KB)
Mode of Action
Further Understanding of Recombinant Activated Factor VII Mode of Action Dougald M. Monroe pages S7-S11 Abstract | Full Text | Full-Text PDF (520 KB)
Tissue Factor–Independent Effects of Recombinant Factor VIIa on Hemostasis Cees Weeterings, Ton Lisman, Philip G. de Groot pages S12-S15 Abstract | Full Text | Full-Text PDF (117 KB)
Platelet Tissue Factor: How Did It Get There and Is It Important? Nigel S. Key pages S16-S20 Abstract | Full Text | Full-Text PDF (286 KB)
Factor VIIa Interaction With Tissue Factor and Endothelial Cell Protein C Receptor on Cell Surfaces Usha R. Pendurthi, L. Vijaya Mohan Rao pages S21-S24 Abstract | Full Text | Full-Text PDF (866 KB)
Treating Patients Who Have Haemophilia and Inhibitors
Monitoring Inhibitor Patients With the Right Assays Trevor W. Barrowcliffe pages S25-S30 Abstract | Full Text | Full-Text PDF (269 KB)
Investing in Hemophilia Care: Benefits and Costs for Patients and Society Luciana Scalone pages S31-S34 Abstract | Full Text | Full-Text PDF (92 KB)
Use of Single Dose
A Prospective, Observational, Post-approval Registry of Inhibitor Patients Treated With Multiple or Single Doses of Recombinant Activated Factor VII Hervé Chambost pages S35-S37 Abstract | Full Text | Full-Text PDF (81 KB)
Single-Dose Recombinant Activated Factor VII Therapy in Hemophilia Patients With Inhibitors Gili Kenet, Uri Martinowitz pages S38-S41 Abstract | Full Text | Full-Text PDF (94 KB)
Orthopaedic Management
Arthropathy in Inhibitor Patients: Differences in the Joint Status W. Keith Hoots pages S42-S49 Abstract | Full Text | Full-Text PDF (254 KB)
Blood-Induced Joint Disease: The Confluence of Dysregulated Oncogenes, Inflammatory Signals, and Angiogenic Cues Leonard A. Valentino, Narine Hakobyan, Candace Enockson pages S50-S57 Abstract | Full Text | Full-Text PDF (3477 KB)
Orthopedic Management in Hemophilia: A Spanish Outlook E. Carlos Rodriguez-Merchan pages S58-S63 Abstract | Full Text | Full-Text PDF (444 KB)
Controversies and Challenges in Elective Orthopedic Surgery in Patients With Hemophilia and Inhibitors Victor Jiménez-Yuste, E. Carlos Rodriguez-Merchan, Maria Teresa Alvarez, Manuel Quintana, Ihosvany Fernandez, Fernando Hernandez-Navarro pages S64-S67 Abstract | Full Text | Full-Text PDF (88 KB)
Other Developments
On-Label Versus Off-Label Use of Recombinant Activated Factor VII: A Comprehensive Review of Use in Two Canadian Centers Manuel D. Carcao, Kathryn E. Webert pages S68-S71 Abstract | Full Text | Full-Text PDF (119 KB)
Prize Poster Presentations
Use of the Thrombin Generation Test to Evaluate Response to Treatment With Recombinant Activated Factor VII Yesim Dargaud, Jean-Claude Bordet, Anne Lienhart, Claude Negrier pages S72-S73 Full Text | Full-Text PDF (244 KB)
Successful Control of Central Nervous System Bleeding in Two Newborns With Severe Factor VII Deficiency Using rFVIIa Administered via Port-a-Cath Mehran Karimi page S74 Abstract | Full-Text PDF (52 KB)
Frontmatter
Suppl TOC pages A1-A2 Full-Text PDF (35 KB)
Supplement Disclaimer page A3 Full-Text PDF (18 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
